Heart failure unit. Why do we need it?

5/15/2024

Challenges in Cardiology

0:00

27:31

Heart Failure - Chronic Worsening Acute

More episodes from "Challenges in Cardiology"

Icosapent ethyl: a new option for patients with acute coronary syndromes
9/19/2024
23:31
Residual Risk - An ongoing goal for cardiovascular prevention
REDUCE-IT: lessons from a landmark clinical trial
6/17/2024
28:17
Residual Risk - An ongoing goal for cardiovascular prevention
Don't miss an episode of “Challenges in Cardiology” and subscribe to it in the GetPodcast app.
Risk reduction beyond lipid lowering - Jorge Ferreira
6/3/2024
21:10
Residual Risk - An ongoing goal for cardiovascular prevention
Therapy beyond the four pillars
5/22/2024
26:59
Heart Failure - Chronic Worsening Acute
Triglyceride: another important predictor of CVD risk - Cristina Gavina
5/20/2024
24:39
Residual Risk - An ongoing goal for cardiovascular prevention
Heart failure unit. Why do we need it?
5/15/2024
27:31
Heart Failure - Chronic Worsening Acute
Vitoria trial. Implications for our daily clinical practice
5/8/2024
23:00
Heart Failure - Chronic Worsening Acute
Heart failure, a multidisciplinary approach
4/30/2024
22:21
Heart failure - Chronic Worsening Acute
Why patients with heart failure die? The role of arrhythmologist
4/24/2024
23:48
Heart failure - Chronic Worsening Acute
Coronary angioplasty in women. How is it different?
6/21/2023
15:16
João Morais à conversa com Marco Costa. O chairman do Challenges in Cardiology e diretor do Serviço de Cardiologia e Coordenador do Centro de Investigação do Centro Hospitalar de Leiria debate as particularidades da angioplastia coronária nas mulheres com Marco Costa, coordenador da Unidade de Intervenção Cardiovascular do Centro Hospitalar e Universitário de Coimbra. Um episódio da série de podcasts "Cardiovascular Health in Women", apoiada pela Organon.

More Episodes

Get the whole world of podcasts with the free GetPodcast app.

Subscribe to your favorite podcasts, listen to episodes offline and get thrilling recommendations.

A company from

Heart failure unit. Why do we need it?

Challenges in Cardiology

More episodes from "Challenges in Cardiology"

Icosapent ethyl: a new option for patients with acute coronary syndromes

REDUCE-IT: lessons from a landmark clinical trial

Risk reduction beyond lipid lowering - Jorge Ferreira

Therapy beyond the four pillars

Triglyceride: another important predictor of CVD risk - Cristina Gavina

Heart failure unit. Why do we need it?

Vitoria trial. Implications for our daily clinical practice

Heart failure, a multidisciplinary approach

Why patients with heart failure die? The role of arrhythmologist

Coronary angioplasty in women. How is it different?